FdaApplication
BLA 761149
Identifiers
- fda_app_no: BLA761149
Properties
| Property | Value |
|---|---|
| applicant_name | Genentech, Inc. |
| application_type | BLA |
| approval_date | 2020-08-14 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ENSPRYNG | SATRALIZUMAB | 120MG/ML | Injection |
1 product